Tirzepatide (Mounjaro/Zepbound) for weight management and glycemic control
However, as is the case with xenosiderophores, iron-containing chelating molecules such as desferrioxamine B (DFO), used in the treatment of iron-loading disorders, can be utilised as an iron source by bacteria that harbour the necessary receptor, including NTHi (Williams et al., 1990
Yoshizumi, M., Watanabe, C
While the science is promising, most evidence comes from small-scale or preclinical studies rather than large clinical trials
and (3) acting as a precursor for the synthesis of phytochelatins (PCs)
Pairing a local repair signal with a systemic one is the rationale behind the combination